Brazil Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Brazil Pharmaceuticals and Healthcare Report Q3 2013 Jun 12th 2013, 00:00 BMI View: The Brazilian government has become increasingly proactive in supporting local pharmaceutical industry. At a time when the public sector is trying to balance increasing demand for healthcare with the need to control public healthcare spending, the attractions of the private healthcare sector are substantial to foreign investors due to the country’s positive long-term economic outlook, growing middle-class population and its traditional commitment to improve healthcare. Headline Expenditure Projections ? Pharmaceuticals: BRL52.4bn (US$26.8bn) in 2012 to BRL57.0bn (US$27.5bn) in 2013; +8.7% in local currency terms and 6.3% in US dollars terms. Forecast remains the same as in Q213. ? … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=100878. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/brazil-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions